Mahzi Therapeutics
PrivateLast Round
Grant
Mar 27, 2026
Total Funding Raised
$47.79M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Mahzi Therapeutics is a biotechnology company that develops precision therapies for rare genetic neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mahzi Therapeutics Comparables
Compare Mahzi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurogene | 79% | |
| Capsida Biotherapeutics | 77% | |
| Encoded Therapeutics | 76% | |
Mahzi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 27, 2026 | ||||
| Grant | Jan 30, 2025 | ||||
| Grant | Jun 27, 2024 | ||||
| Grant | Nov 29, 2022 | ||||
| Early Funding | Oct 7, 2021 | ||||
Seed | Dec 1, 2020 |
Key People
Founding team and executive leadership
Mahzi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Early Funding |
| HealthCap | Early Funding |
| ArrowMark Partners | Early Funding |
| HBM Healthcare Investments | Early Funding |
| California Institute for Regenerative Medicine | Grant |
| Venrock | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
$8M grant from California Institute for Regenerative Medicine.
Mahzi Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mahzi Therapeutics's valuation, stock price, and market status.